The PE Ratio as of December 2025 (TTM) for SynAct Pharma AB (SYNACT.ST) is -9.47

According to SynAct Pharma AB’s latest financial reports and current stock price. The company's current PE Ratio is -9.47. This represents a change of 27.60% compared to the average of -7.42 of the last 4 quarters.

SynAct Pharma AB (SYNACT.ST) Historical PE Ratio (quarterly & annually)

How has SYNACT.ST PE Ratio performed in the past?

The mean historical PE Ratio of SynAct Pharma AB over the last ten years is -17.59. The current -9.47 PE Ratio has changed 5.28% with respect to the historical average. Over the past ten years (40 quarters), SYNACT.ST's PE Ratio was at its highest in in the December 2023 quarter at -0.87. The PE Ratio was at its lowest in in the June 2021 quarter at -53.15.

SynAct Pharma AB (SYNACT.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of SynAct Pharma AB PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SynAct Pharma AB (SYNACT.ST) Average PE Ratio

How has SYNACT.ST PE Ratio performed in the past?

The current PE Ratio of SynAct Pharma AB (SYNACT.ST) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

SynAct Pharma AB (SYNACT.ST) PE Ratio vs. Peers

How is SYNACT.ST’s PE Ratio compared to its peers?

SynAct Pharma AB’s PE Ratio is less than Oncopeptides AB (publ) (-4.35), less than Xspray Pharma AB (publ) (-5.41), less than I-Tech AB (15.99), less than Infant Bacterial Therapeutics AB (publ) (-8.45), less than Diamyd Medical AB (publ) (-7.86), less than Genovis AB (publ.) (63.92), less than Orexo AB (publ) (-4.30), greater than Sedana Medical AB (publ) (-25.86), less than Cantargia AB (publ) (7.83), less than C-Rad AB (publ) (45.72),

Build a custom stock screener for SynAct Pharma AB (SYNACT.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SynAct Pharma AB using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SynAct Pharma AB (SYNACT.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SynAct Pharma AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.